Comparison of hangover effects among triazolam, flunitrazepam and quazepam in healthy subjects: A preliminary report

Psychiatry and Clinical Neurosciences

Volumn 57, Issue 3, 2003, Pages 303-309

  Takahashi, Taro ^a   Okajima, Yuka ^a   Otsubo, Tempei ^a   Shinoda, Junko ^a   Mimura, Masaru ^a   Nakagome, Kazuyuki ^a   Kamijima, Kunitoshi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Actigraphy; Benzodiazepine; Flunitrazepam; Hangover; MSLT; Quazepam; Triazolam

Indexed keywords

FLUNITRAZEPAM; HYPNOTIC AGENT; QUAZEPAM; TRIAZOLAM;

ACTIMETRY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG HALF LIFE; FEMALE; HANGOVER; HUMAN; MALE; NORMAL HUMAN; PERFORMANCE; PSYCHOMOTOR ACTIVITY; SEDATION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SLEEP; SOMNOLENCE;

ACTIVITIES OF DAILY LIVING; ADULT; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CROSS-OVER STUDIES; FATIGUE; FEMALE; FLUNITRAZEPAM; HUMANS; HYPNOTICS AND SEDATIVES; MALE; SINGLE-BLIND METHOD; SLEEP DISORDERS; TRIAZOLAM;

EID: 0037677510     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2003.01121.x     Document Type: Article

References (33)

1. Billard W, Crosby G, Iorio L, Chipkin R, Barnett A. Selective affinity of the benzodiazepines quazepam and 2-oxo-quazepam for BZ1 binding site and demonstration of 3H-2-oxo-quazepam as a BZ1 selective radioligand. Life Sci. 1988; 42: 179-187.
2. Miller LG, Galpern WR, Byrnes JJ, Greenblatt DJ. Benzodiazepine receptor binding of benzodiazepine hypnotics: Receptor and ligand specificity. Pharmacol. Biochem. Behav. 1992; 43: 413-416.
3. Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, Kales JD. Quazepam and flurazepam: Long-term use and extended withdrawal. Clin. Pharmacol. Ther. 1982; 32: 781-788.
4. Dement WC. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the multiple sleep latency test. J. Clin. Psychiatry 1991; 52 (Suppl. 9): 31-37.
5. Saletu B, Anderer P, Brandstätter N et al. Insomnia in generalized anxiety disorder: Polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). Neuropsychobiology 1994; 29: 69-90.
6. Roth TG, Roehers TA, Koshorek GL, Greenblatt DJ, Rosenthal LD. Hypnotic effects of low doses of quazepam in older insomniacs. J. Clin. Psychopharmacol. 1997; 17: 401-406.
7. Mendels J. Evaluation of the safety and efficacy for the treatment of insomnia in psychiatric outpatients. J. Clin. Psychiatry 1994; 55: 60-65.
8. Inagaki A, Inada T, Fujii Y, Yagi G. Dose equivalence of anxiolytic drugs, sedatives and hypnotics. In: Inagaki A, Inada T, Fujii Y et al. (eds). Dose Equivalence of Psychotropic Drugs. Seiwa Publishers, Tokyo, 1999; 99-121.
9. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: A new approach. Psychophysiology 1973; 10: 431-436.
10. Parrot AC, Hindmarch I. Factor analysis of a sleep evaluation questionnaire. Psychol. Med. 1978; 8: 325-329.
11. Lemke MR, Broderick A, Zeitelberger M, Hartmann W. Motor activity and daily variation of symptom intensity in depressed patients. Neuropsychobiology 1997; 36: 57-61.
12. Ancoli-Israel S, Clopton P, Klauber MR, Fell R, Mason W. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 1997; 20: 24-27.
13. Broughton R, Fleming J, Fleetham J. Home assessment of sleep disorders by portable monitoring. J. Clin. Neurophysiol. 1996; 13: 272-284.
14. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness. Sleep 1986; 9: 519-524.
15. Rechtschäffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stage of human subjects. Public Health Services. US Government Printing Office, Washington, 1968.
16. Cornblatt BA, Lenzenweger MR, Erlenmeyer-Kimling L. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res. 1989; 26: 223-238.
17. Nuechterlein KH. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. J. Abnorm. Psychol. 1983; 92: 4-28.
18. Kales A. Quazepam: Hypnotic efficacy and side effects. Pharamacotherapy 1990; 10: 1-12.
19. Kales A, Bixler EO, Vela-Bueno A, Soldatos CR, Niklaus DE, Manfredi RL. Comparison of short and long half-life benzodizepine hypnotics: Triazolam and quazepam. Clin. Pharmacol. Ther. 1986; 40: 378-386.
20. Nikaido AM, Ellinwood EH. Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance. Psychopharmacology 1992; 92: 459-464.
21. Schaffler K, Kauert G, Wauschkuhn CH, Klausnitzer W. Longitudinal study on pharmacokinetics of acute, steadystate and withdrawn quazepam. Arzneimittelforshung 1989; 39: 276-283.
22. Lee A, Lader M. Tolerance and rebound during and after short-term administration of quazepam, triazolam and placebo to healthy volunteers. Int. Clin. Psychopharmacol. 1988; 3: 31-47.
23. Bocca ML, Le Doze F, Etard O, Pottier M, L'Hoste J, Denise P. Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacology 1999; 143: 373-379.
24. Bensimon G, Foret J, Warot D, Lacomblez L, Thiercelin JF, Simon P. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo. Br. J. Clin. Pharmacol. 1990; 30: 463-469.
25. Smirne S, Ferini-Strambi L, Pirola R et al. Effects of flunitrazepam on cognitive functions. Psychopharmacology 1989; 98: 251-256.
26. Harrison C, Subhan Z, Hindmarch I. Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving. Drugs Exp. Clin. Res. 1985; 11: 823-829.
27. Sjövall S, Kanto J, Kangas L, Pakkanen A. Comparison of midazolam and flunitrazepam for night sedation. A randomized double-blind study. Anaesthesia 1982; 37: 924-928.
28. Lader M, Melhuish A, Harris P. Residual effects of repeated doses of 0.5 and 1 mg flunitrazepam. Eur. J. Clin. Pharmacol. 1982; 23: 135-140.
29. Mattmann P, Loepfe M, Scheitlin T et al. Day-time residual effects and motor activity after three benzodiazepine hypnotics. Arzneimittelforschung 1982; 32: 461-465.
30. Bond AJ, Lader MH. Residual effects of flunitrazepam. Br. J. Clin. Pharmacol. 1975; 2: 143-150.
31. Hindmarch I. A repeated dose comparison of three benzodiazepine derivative (nitrazepam, flurazepam and flunitrazepam) on subjective appraisals of sleep and measures of psychomotor performance the morning following night-time medication. Acta Psychiatr. Scand. 1977; 56: 373-381.
32. Rush CR, Ali JA. A follow-up study of the acute benzodiazepine effects of benzodiazepine-receptor ligands in humans: Comparison of quazepam and triazolam. Exp. Clin. Psychopharmacol. 1999; 7: 257-265.
33. Carskadon MA, Seidel WF, Greenblatt DJ, Dement WC. Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 1982; 5: 361-371.